肝病：非酒精性脂肪性肝炎中的有意识解偶联 - Suppr

Suppr

超能文献

Liver disease: Conscious uncoupling in NASH.

作者信息

Villanueva M Teresa

出版信息

Nat Rev Drug Discov. 2017 Mar 30;16(4):238-239. doi: 10.1038/nrd.2017.60.

DOI:10.1038/nrd.2017.60

PMID:28356593

Abstract

摘要

相似文献

Liver disease: Conscious uncoupling in NASH.肝病：非酒精性脂肪性肝炎中的有意识解偶联

Nat Rev Drug Discov. 2017 Mar 30;16(4):238-239. doi: 10.1038/nrd.2017.60.

Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates.靶向胱天蛋白酶 8 和 FADD 样凋亡调节蛋白可改善小鼠和非人灵长类动物的非酒精性脂肪性肝炎。

Nat Med. 2017 Apr;23(4):439-449. doi: 10.1038/nm.4290. Epub 2017 Feb 20.

Apoptosis signal-regulating kinase-1 as a therapeutic target in nonalcoholic fatty liver disease.凋亡信号调节激酶-1作为非酒精性脂肪性肝病的治疗靶点

Expert Rev Gastroenterol Hepatol. 2019 Mar;13(3):189-191. doi: 10.1080/17474124.2019.1570136. Epub 2019 Jan 24.

Review article: new treatments in non-alcoholic fatty liver disease.综述文章：非酒精性脂肪性肝病的新疗法

Aliment Pharmacol Ther. 2017 Sep;46(5):494-507. doi: 10.1111/apt.14210. Epub 2017 Jul 4.

Emerging therapies for NASH - the future is now.非酒精性脂肪性肝炎的新兴疗法——未来已来。

Expert Rev Clin Pharmacol. 2017 May;10(5):467-469. doi: 10.1080/17512433.2017.1305269.

Pharmacological management of nonalcoholic fatty liver disease in type 2 diabetes.2 型糖尿病中非酒精性脂肪性肝病的药物治疗管理。

Expert Rev Clin Pharmacol. 2017 May;10(5):535-547. doi: 10.1080/17512433.2017.1300059. Epub 2017 Mar 6.

An antiapoptotic protein, c-FLIPL, directly binds to MKK7 and inhibits the JNK pathway.一种抗凋亡蛋白，c-FLIPL，直接与MKK7结合并抑制JNK信号通路。

EMBO J. 2006 Nov 29;25(23):5549-59. doi: 10.1038/sj.emboj.7601423. Epub 2006 Nov 16.

Treatment options for nonalcoholic steatohepatitis - a safety evaluation.非酒精性脂肪性肝炎的治疗选择——安全性评估

Expert Opin Drug Saf. 2017 Aug;16(8):903-913. doi: 10.1080/14740338.2017.1343299. Epub 2017 Jul 6.

Apoptosis triggered by phagocytosis-related oxidative stress through FLIPS down-regulation and JNK activation.通过FLIPS下调和JNK激活，由吞噬作用相关的氧化应激触发的细胞凋亡。

J Leukoc Biol. 2007 Nov;82(5):1344-52. doi: 10.1189/jlb.0407259. Epub 2007 Aug 20.

Effect of resveratrol on experimental non-alcoholic fatty liver disease depends on severity of pathology and timing of treatment.白藜芦醇对实验性非酒精性脂肪性肝病的影响取决于病理严重程度和治疗时机。

J Gastroenterol Hepatol. 2016 Mar;31(3):668-75. doi: 10.1111/jgh.13151.

引用本文的文献

LPJZ-658 Improves Non-Alcoholic Steatohepatitis by Modulating Bile Acid Metabolism and Gut Microbiota in Mice.LPJZ-658 通过调节胆汁酸代谢和肠道微生物群改善小鼠非酒精性脂肪性肝炎。

Int J Mol Sci. 2023 Sep 12;24(18):13997. doi: 10.3390/ijms241813997.

Perilipin5 protects against non-alcoholic steatohepatitis by increasing 11-Dodecenoic acid and inhibiting the occurrence of ferroptosis.perilipin5通过增加11-十二碳烯酸和抑制铁死亡的发生来预防非酒精性脂肪性肝炎。

Nutr Metab (Lond). 2023 Jun 22;20(1):29. doi: 10.1186/s12986-023-00751-2.

UDP-glucuronate metabolism controls RIPK1-driven liver damage in nonalcoholic steatohepatitis.UDP-葡萄糖醛酸代谢控制非酒精性脂肪性肝炎中 RIPK1 驱动的肝损伤。

Nat Commun. 2023 May 11;14(1):2715. doi: 10.1038/s41467-023-38371-2.

Tripartite motif 38 alleviates the pathological process of NAFLD-NASH by promoting TAB2 degradation.三结构域蛋白 38 通过促进 TAB2 降解来减轻 NAFLD-NASH 的病理过程。

J Lipid Res. 2023 Jul;64(7):100382. doi: 10.1016/j.jlr.2023.100382. Epub 2023 Apr 26.

SENP1 prevents steatohepatitis by suppressing RIPK1-driven apoptosis and inflammation.SENP1 通过抑制 RIPK1 驱动的细胞凋亡和炎症来预防脂肪性肝炎。

Nat Commun. 2022 Nov 22;13(1):7153. doi: 10.1038/s41467-022-34993-0.

Hepatocyte phosphatase DUSP22 mitigates NASH-HCC progression by targeting FAK.肝细胞磷酸酶 DUSP22 通过靶向 FAK 减轻 NASH-HCC 进展。

Nat Commun. 2022 Oct 8;13(1):5945. doi: 10.1038/s41467-022-33493-5.

Crystallographic mining of ASK1 regulators to unravel the intricate PPI interfaces for the discovery of small molecule.对ASK1调节因子进行晶体学挖掘，以揭示复杂的蛋白质-蛋白质相互作用界面，从而发现小分子。

Comput Struct Biotechnol J. 2022 Jul 11;20:3734-3754. doi: 10.1016/j.csbj.2022.07.008. eCollection 2022.

Glutathione S-transferase Mu 2 inhibits hepatic steatosis via ASK1 suppression.谷胱甘肽 S-转移酶 Mu2 通过抑制 ASK1 抑制肝脂肪变性。

Commun Biol. 2022 Apr 6;5(1):326. doi: 10.1038/s42003-022-03251-w.

Breviscapine alleviates NASH by inhibiting TGF-β-activated kinase 1-dependent signaling.灯盏花素通过抑制 TGF-β 激活激酶 1 依赖性信号通路缓解 NASH。

Hepatology. 2022 Jul;76(1):155-171. doi: 10.1002/hep.32221. Epub 2021 Dec 19.

Glycoursodeoxycholic acid ameliorates diet-induced metabolic disorders with inhibiting endoplasmic reticulum stress.甘氨熊脱氧胆酸通过抑制内质网应激改善饮食诱导的代谢紊乱。

Clin Sci (Lond). 2021 Jul 30;135(14):1689-1706. doi: 10.1042/CS20210198.

本文引用的文献

Nat Med. 2017 Apr;23(4):439-449. doi: 10.1038/nm.4290. Epub 2017 Feb 20.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验